Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
In: Tropical Medicine and Infectious Disease; Volume 6; Issue 1; Pages: 13, 2021
academicJournal
Zugriff:
In Mali, since 2007, artemether-lumefantrine has been the first choice against uncomplicated malaria. Despite its effectiveness, a rapid selection of markers of resistance to partner drugs has been documented. This work evaluated the treatment according to the World Health Organization’s standard 28-day treatment method. The primary endpoint was the clinical and parasitological response corrected by a polymerase chain reaction. It was more than 99.9 percent, the proportion of patients with anemia significantly decrease compared to baseline (p < 0.001), and no serious events were recorded. Plasmodium falciparum remains sensitive to artemether-lumefantrine in Mali.
Titel: |
Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali
|
---|---|
Autor/in / Beteiligte Person: | Diarra, Modibo ; Coulibaly, Drissa ; Tapily, Amadou ; Guindo, Boureima ; Sanogo, Koualy ; Koné, Diakalia ; Koné, Youssouf ; Koné, Karim ; Bathily, Aboudramane ; Yattara, Oumar ; Thera, Mahamadou A. ; Dicko, Alassane ; Djimdé, Abdoulaye A. ; Sagara, Issaka |
Link: | |
Zeitschrift: | Tropical Medicine and Infectious Disease; Volume 6; Issue 1; Pages: 13, 2021 |
Veröffentlichung: | Multidisciplinary Digital Publishing Institute, 2021 |
Medientyp: | academicJournal |
DOI: | 10.3390/tropicalmed6010013 |
Schlagwort: |
|
Sonstiges: |
|